Stock & Company Details
Galectin Therapeutics Inc $GALT
Price:
N/A
N/A
101M
$367M
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.93
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GALT technical indicators
Latest Galectin Therapeutics Inc (GALT) indicator readings as of 2026-10-09.
GALT's 14-day RSI is 53.0, in neutral territory. At $3.94 it is trading 22.3% above its 200-day moving average of $3.22, and above its 50-day average of $3.75. Price sits in the middle of its Bollinger Bands ($3.58 to $4.12). ADX reads 15.9, indicating a range-bound market rather than a trend.
Overview
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Finance Bot
Ask your questions
Start by typing a question below.
